Opdivo/Cabometyx Combo ‘Very Encouraging' In 1L RCC

But Competition Intensifying

 
• By Ian Haydock
Kidney cancer
New Opdivo Combo Looks Good In RCC • Source: Shutterstock

More from Immuno-oncology

More from Anticancer